Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults

NCT06684743 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

690000

Enrollment

OTHER

Sponsor class

Conditions

RSV

Interventions

BIOLOGICAL: RSV prefusion F protein-based vaccine

Sponsor

Tor Biering-Sørensen

Collaborators

[object Object]